1. World Health Organization.Coronavirus disease (COVID-19) general informations. Web page. 2023. https://www.who.int/health-topics/coronavirus#tab=tab_1 [Accessed 7 February 2023].
2. European Medicines Agency. Nirmatrelvir/ritonavir informations. Last update on January 25, 2023. https://www.ema.europa.eu/en/medicines/human/EPAR/paxlovid [Accessed 7 February 2023].
3. European Medicines Agency.Summary of product characteristics. Paxlovid. 2022. https://www.ema.europa.eu/en/documents/product-information/paxlovid-epar-product-information_en.pdf [Accessed 7 February 2023 (44 pp)].
4. European Medicines Agency.Warning about monoclonal antibodies against emerging strains of SARS-CoV-2. December 09, 2022. https://www.ema.europa.eu/en/news/etf-warns-monoclonal-antibodies-may-not-be-effective-against-emerging-strains-sars-cov-2 [Accessed 7 February 2023].
5. Causality assessment in pharmacovigilance: the French method and its successive updates;Miremont-Salamé;Therapie,2016